Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 19Classical hematology 2Sarcoma 1Other 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Obesity 373Neoplasms 134Breast Neoplasms 95Mucositis 94Overweight 91Sexual Dysfunction, Physiological 90Polycystic Ovary Syndrome 89Dyspnea 56Motor Activity 54Weight Loss 38Constipation 35Diabetes Mellitus 33Prostatic Neoplasms 32Head and Neck Neoplasms 30Colorectal Neoplasms 30Endometrial Neoplasms 26Lung Neoplasms 25Depression 25Diabetes Mellitus, Type 2 23Cardiovascular Diseases 23Multiple Endocrine Neoplasia Type 1 22Pain 20Anxiety Disorders 20Insulin Resistance 19Obesity, Morbid 18Pulmonary Disease, Chronic Obstructive 17Hypertension 17Sexual Dysfunctions, Psychological 16Metabolic Syndrome 16Colonic Neoplasms 16

Interventions

Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Seizures × Other × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡